ACIU
AC Immune Ltd
NASDAQ: ACIU · HEALTHCARE · BIOTECHNOLOGY
$2.97
-1.33% today
Updated 2026-05-06
Market cap
$303.29M
P/E ratio
—
P/S ratio
84.88x
EPS (TTM)
$-0.84
Dividend yield
—
52W range
$2 – $4
Volume
0.3M
AC Immune Ltd (ACIU) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-19.80M | $-17.62M | $44.08M | $-5.65M | $-22.09M | $-44.08M | $55.22M | $-59.52M | $-65.69M | $-73.57M | $-60.41M | $65.84M | $-66.15M |
| Capital expenditures | $249000.00 | $128000.00 | $244000.00 | $899000.00 | $1.80M | $1.86M | $1.89M | $1.71M | $2.63M | $1.24M | $801000.00 | $576000.00 | $859541.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $256000.00 | $210000.00 | $540000.00 | $1.32M | $1.58M | $2.52M | $2.83M | $4.09M | $4.13M | $3.33M | $4.37M | $5.47M | $4.40M |
| Free cash flow | $-20.05M | $-17.75M | $43.84M | $-6.54M | $-23.90M | $-45.94M | $53.34M | $-61.22M | $-68.32M | $-74.81M | $-61.21M | $65.27M | $-67.01M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | $7000.00 | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — |